Sun Pharma’s latest US agreement comes as the drugmaker expands its presence in innovative medicines, with America accounting for 27% of its global revenue and the $11.75 billion Organon acquisition reinforcing its long-term bet on the market.
This article was aggregated from Business Today. Continue reading for the complete story.
Read on Business Today
Besides new production, HAL's Nashik facility is expected to play a key role in a major upgrade of the existing Su-30MKI fleet.
Business Today
undefined
Business Today
India’s ambition to become a global manufacturing powerhouse is accelerating, with the automobile industry at the centre of this transformation. In this #IndiaAt100 session, Hisashi Takeuchi, MD & CEO, Maruti Suzuki India, discusses how manufacturing can drive India’s next phase of growth. From loca
Business Today
For Nuvama, Kaynes Tech’s Q1 print was a mixed bag. It noted that Kaynes' profit fell 24 per cent YoY, which was 7 per cent below its estimate, led by lower other income and higher tax rate.
Business Today
